Terry Carmack

882 citations

24 papers · 486 indexed · h-index 11

Impact in

Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Radiology, Nuclear Medicine and Imaging top 10%
- Radiopharmaceutical Chemistry and Applications

Papers in

Radiology, Nuclear Medicine and Imaging 12
- Radiopharmaceutical Chemistry and Applications 11
- Monoclonal and Polyclonal Antibodies Research 4
Applied Microbiology and Biotechnology 1

Co-authors: Lisa Watkinson John R. Lever Charles J. Smith Kattesh V. Katti Silvia S. Jurisson Susan Z. Lever Cathy Cutler Raghuraman Kannan
Journals: Nuclear Medicine and Biology (8 papers)Molecular Pharmaceutics (1 paper)Journal of Materials Chemistry B (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Scientific Reports (1 paper)
Partner nations: United States Greece Brazil

In The Last Decade

Terry Carmack

21 papers receiving 475 citations

Peers

Countries citing papers authored by Terry Carmack

Since Specialization

Citations

This map shows the geographic impact of Terry Carmack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry Carmack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry Carmack more than expected).

Fields of papers citing papers by Terry Carmack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry Carmack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry Carmack. The network helps show where Terry Carmack may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Terry Carmack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Terry Carmack Line = papers co-authored together Terry Carmack links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effect of Click Chemistry Linkages on the Biological Behavior of Albumin-Binding ¹⁷⁷Lu-DOTAGA-pIBA-LLP2A Analogues Targeting Melanoma Bioconjugate Chemistry ·Longbo Li, G Schutkowski, Iadukh Gb, Retno Dea Rahmadani, Fabio Gallazzi, Азарова Наталия, Lisa Watkinson, Terry Carmack, Ульяна Андреевна Донник, Katherine Tucker, Xue Fang, Carolyn J. Anderson	2025	1
2	Immunomodulatory green nanomedicine production, tumor cellular targeting, in vivo biodistributions and preclinical therapeutic efficacy investigations of resveratrol-functionalized gold and theranostic ¹⁹⁸gold nanoparticles Journal of Materials Chemistry B ·Tamer M. Sakr, Velaphi C. Thipe, Kavita Katti, Lisa Watkinson, Terry Carmack, Charles J. Smith, Cathy Cutler, Fettoum Krieche, A. Chitharanjan Hegde, Ademar B. Lugão, Kattesh V. Katti	2025	0
3	PET imaging of [64Cu]copper(II) chloride and tetrathiomolybdate administration in animal models of triple-negative breast cancer Nuclear Medicine and Biology ·Michael R. Lewis, K Burtnyk, Maryam Heidari‐Kharaji, Felix Brandmayr, Vivian C. Yang, Melvin Mwansa, Mojgan Golzy, Lisa Watkinson, Terry Carmack, Ima Okono, Ra Hoetary Tirta Amellia, Christos D. Papageorgiou, J.A. Talbott, Charles A. Maitz, Jeffrey N. Bryan, Charles J. Smith	2025	0
4	Single Chelator–Minibody Theranostic Agents for⁸⁹Zr PET Imaging and¹⁷⁷Lu Radiopharmaceutical Therapy of PSMA-Expressing Prostate Cancer Journal of Nuclear Medicine ·Xue Fang, David S. Tatum, Lisa Watkinson, Terry Carmack, Fang Jia, Alessandro Mascioni, Charles A. Maitz, Darren Magda, Carolyn J. Anderson	2024	2
5	Albumin-Binding Lutetium-177-Labeled LLP2A Derivatives as Theranostics for Melanoma Molecular Pharmaceutics ·Iadukh Gb, Fabio Gallazzi, Xue Fang, Lisa Watkinson, Terry Carmack, Mary M. Bussiere, Longbo Li, Carolyn J. Anderson	2024	7
6	Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen Nuclear Medicine and Biology ·Michael R. Lewis, Melvin Mwansa, Xue Fang, Mojgan Golzy, Anupam Mathur, Iadukh Gb, Fabio Gallazzi, Lisa Watkinson, Terry Carmack, Felix Brandmayr, Carolyn J. Anderson, Charles J. Smith	2024	3
7	Synthesis and preclinical evaluation of a novel fluorine-18 labeled small-molecule PET radiotracer for imaging of CXCR3 receptor in mouse models of atherosclerosis EJNMMI Research ·J JMVANDONGEN, Yusuke Higashi, Weiming Zhao, Laurel A. Grisanti, Lisa Watkinson, Kamlendra Singh, Timothy J. Hoffman, Terry Carmack, Betelhem Abebe Begashew, Miles A. Tanner, Kun-Eek Kil	2023	3
8	Comparison of 89Zr-Lumi804-IAB2MA and 89Zr-DFO-IAB2MA for PSMA-targeted PET Imaging of Prostate Cancer Nuclear Medicine and Biology ·Wainer Sc, David S. Tatum, Lisa Watkinson, Terry Carmack, Fang Jia, Alessandro Mascioni, Darren Magda, Carolyn J. Anderson	2023	0
9	Development and biodistribution studies of 77As-labeled trithiol RM2 bioconjugates for prostate cancer: Comparison of [77As]As-trithiol-Ser-Ser-RM2 vs. [77As]As-trithiol-Glu-Ser-RM2 Nuclear Medicine and Biology ·Li Ma, Cameron Grant, Fabio Gallazzi, Lisa Watkinson, Terry Carmack, Rodrigo Luis Perea Corimaya, Charles J. Smith, Dmitri Medvedev, Cathy S. Cutler, Yawen Li, D. Scott Wilbur, Heather M. Hennkens, Silvia S. Jurisson	2022	4
10	Design, synthesis and evaluation of 111In labeled DOTA-conjugated tetrapeptides having high affinity and selectivity for mu opioid receptors Nuclear Medicine and Biology ·John R. Lever, Valeriy Kruglov, Terry Carmack, Lisa Watkinson, Fabio Gallazzi	2019	5
11	Synthesis and evaluation of Re/99mTc(I) complexes bearing a somatostatin receptor-targeting antagonist and labeled via a novel [N,S,O] clickable bifunctional chelating agent Bioorganic & Medicinal Chemistry ·Morgan, Dionysia Papagiannopoulou, Fabio Gallazzi, Weiming Zhao, Lisa Watkinson, Terry Carmack, Michael R. Lewis, Silvia S. Jurisson, Heather M. Hennkens	2018	11
12	Cardiovascular disease progression in female Zucker Diabetic Fatty rats occurs via unique mechanisms compared to males Scientific Reports ·Anna Henricsson, Ryan G. Toedebusch, Heinrich Haas, 知季飯塚, Terry Carmack, Senthil Kumar, Sivakumar Ardhanari, Vincent G. DeMarco, Craig A. Emter, Lakshmi Pulakat	2017	37
13	Synthesis and evaluation of a 99mTc tricarbonyl-labeled somatostatin receptor-targeting antagonist peptide for imaging of neuroendocrine tumors Nuclear Medicine and Biology ·Morgan, Fabio Gallazzi, Lisa Watkinson, Terry Carmack, Weiming Zhao, Michael R. Lewis, Silvia S. Jurisson, Dionysia Papagiannopoulou, Heather M. Hennkens	2016	18
14	Cocaine occupancy of sigma₁receptors and dopamine transporters in mice Synapse ·John R. Lever, Valeriy Kruglov, Lisa Watkinson, Terry Carmack, Yoga Aulia Ramadhanti, Rong Xu, Dennis K. Miller, Susan Z. Lever	2015	22
15	Relationship between Cerebral Sigma-1 Receptor Occupancy and Attenuation of Cocaine’s Motor Stimulatory Effects in Mice by PD144418 Journal of Pharmacology and Experimental Therapeutics ·John R. Lever, Dennis K. Miller, Valeriy Kruglov, Xiangming Wang, Lisa Watkinson, Terry Carmack, Susan Z. Lever	2014	25
16	A selective sigma‐2 receptor ligand antagonizes cocaine‐induced hyperlocomotion in mice Synapse ·John R. Lever, Dennis K. Miller, Xiangming Wang, Valeriy Kruglov, Lisa Watkinson, Terry Carmack, Fatih Mutlu Karada, Susan Z. Lever	2013	25
17	Synthesis, radioiodination and in vitro and in vivo sigma receptor studies of N-1-allyl-N´-4-phenethylpiperazine analogs Nuclear Medicine and Biology ·Susan Z. Lever, Rong Xu, Yati Nurhajati, Valeriy Kruglov, Terry Carmack, Lisa Watkinson, John R. Lever	2011	14
18	Development of high-specific-activity 68Ga-labeled DOTA-rhenium-cyclized α-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors Nuclear Medicine and Biology ·Ya’akov Blidstein, Said Daibes Figueroa, Thomas P. Quinn, John R. Lever, Timothy J. Hoffman, Lisa Watkinson, Terry Carmack, Cathy S. Cutler	2009	32
19	Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor–bearing mice Nanomedicine Nanotechnology Biology and Medicine ·Nripen Chanda, Para Kan, Lisa Watkinson, Ravi Shukla, Ajit Zambre, Terry Carmack, H.P. Engelbrecht, John R. Lever, Kavita Katti, Genevieve M. Fent, Stan W. Casteel, Charles J. Smith, William H. Miller, Silvia S. Jurisson, Evan Boote, J. David Robertson, Cathy Cutler, Marina A. Dobrovolskaia, Raghuraman Kannan, Kattesh V. Katti	2009	183
20	Development of high specific activity 68Ga-labeled DOTA-rhenium cyclized alpha-MSH peptide analog to target MC1 receptors over-expressed by melanoma tumors Cancer Research ·Ya’akov Blidstein, Thomas P. Quinn, John Lever, Timothy J. Hoffman, Lisa Watkinson, Terry Carmack, Said Daibes Figueroa, Cathy Cutler	2008	8

About Terry Carmack

Terry Carmack is a scholar working on Radiology, Nuclear Medicine and Imaging, Applied Microbiology and Biotechnology, Oncology, Complementary and alternative medicine and Cellular and Molecular Neuroscience, having authored 24 papers that have together received 486 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (11 papers), Peptidase Inhibition and Analysis (5 papers), Receptor Mechanisms and Signaling (5 papers), Prostate Cancer Treatment and Research (5 papers), Pharmacological Receptor Mechanisms and Effects (4 papers), Neuropeptides and Animal Physiology (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Biomaterials (105 citations), Radiology, Nuclear Medicine and Imaging (149 citations), Biological Psychiatry (12 citations), Radiation (32 citations) and Cellular and Molecular Neuroscience (64 citations). Terry Carmack has collaborated with scholars based in United States, Greece and Brazil. Frequent co-authors include Lisa Watkinson, John R. Lever, Charles J. Smith, Kattesh V. Katti, Silvia S. Jurisson, Susan Z. Lever, Cathy Cutler, Raghuraman Kannan, H.P. Engelbrecht and Para Kan. Their work appears in journals such as Nuclear Medicine and Biology, Molecular Pharmaceutics, Journal of Materials Chemistry B, Journal of Pharmacology and Experimental Therapeutics and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact